SCHEMBL2596916

SCHEMBL2596916

CCOC(=O)C1CCN(C(Cc2ccc(-c3noc(-c4cc(OC(C)C)n(CC)n4)n3)cc2)C(F)(F)F)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
S1PR1 P21453 9/20 0.38
S1PR5 Q9H228 5/20 0.38
S1PR4 O95977 2/20 0.38
S1PR3 Q99500 4/20 0.36
MAP4K4 O95819 2/20 0.35
MINK1 Q8N4C8 2/20 0.35
DGAT1 O75907 1/20 0.35
TPH1 P17752 2/20 0.34
DYRK3 O43781 1/20 0.34
ERBB2 P04626 1/20 0.34
PIM1 P11309 1/20 0.34
MARK3 P27448 1/20 0.34
PLK1 P53350 1/20 0.34
CAMK2B Q13554 1/20 0.34
CDC42BPA Q5VT25 1/20 0.34
PIM3 Q86V86 1/20 0.34
SRPK1 Q96SB4 1/20 0.34
MKNK2 Q9HBH9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1740696 0.92 S1PR1 (0.44) S1PR1S1PR5S1PR4S1PR3MAP4K4
SCHEMBL1739401 0.89 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2S1PR1S1PR5S1PR4
SCHEMBL1738132 0.80 S1PR1 (0.47) S1PR1S1PR5S1PR4S1PR3
SCHEMBL1740182 0.80 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2S1PR1S1PR5S1PR3
SCHEMBL1738177 0.78 S1PR1 (0.41) ALDH1A1SMN1; SMN2S1PR1S1PR5S1PR4
SCHEMBL1741300 0.74 S1PR1 (0.52) S1PR1S1PR5S1PR4S1PR3
SCHEMBL1740694 0.72 S1PR1 (0.48) S1PR1S1PR5S1PR4S1PR3MAP4K4
SCHEMBL1739399 0.70 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2S1PR1S1PR3MAP4K4
SCHEMBL1738088 0.70 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2
SCHEMBL1739310 0.70 KDM4E (0.44) ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011144338-A1 PYRAZOLE DERIVATIVES AS S1P1 AGONISTS ALMIRALL, S.A. (ES) 2011-11-24 WO disclosed